Dissociative recombination of the polyatomic ions D3O+ and H3O+ with electrons have been studied at the heavy-ion storage ring CRYRING (Manne Siegbahn Laboratory, Stockholm University). Absolute cross sections have been determined from 0.001 eV to 0.25 eV center-of-mass energy for D3O+ and from 0.001 eV to 28 eV for H3O+. The cross sections are large (7.3×10−13 cm2 for D3O+ and 3.3×10−12 cm2 for H3O+ at 0.001 eV). At low energies, the cross sections for D3O+ are E−1 energy dependent whereas it is slightly steeper for H3O+. A similar E−1 energy dependence was also observed by Mul et al. [J. Phys. B 16, 3099 (1983)] with a merged electron-ion beam technique for both H3O+ and D3O+ and by Vejby-Christensen et al. [Astrophys. J. 483, 531 (1997)] with the ASTRID storage ring in Denmark, who presented relative cross sections for H3O+. A resonance has been observed around 11 eV for H3O+. It reflects an electron capture to Rydberg states converging to an excited ionic core. A similar structure was reported by Vejby-Christensen et al. Our absolute measurements are in fairly good agreement with those from Mul et al., which were first divided by 2 (Mitchell, 1999, private communication) and from Heppner et al. [Phys. Rev. A 13, 1000 (1976)] for H3O+. Thermal rates were deduced from the measured cross sections for electron temperatures ranging from 50 K to 30 000 K. At 300 K, the thermal rate is equal to 7.6×10−7 cm3 s−1 for H3O+ and to 3.5×10−7 cm3 s−1 for D3O+. Complete branching ratios for all the possible product channels have been determined from 0 eV to 0.005 eV center-of-mass energy for D3O+ and at 0 eV for H3O+, using a well-characterized transmission grid in front of an energy-sensitive surface-barrier detector. No isotope effect was observed within the experimental uncertainties. The three-body break-up channel OX+X+X (where X stands for H or D) is found to occur for 67%–70% of the dissociations. Water or heavy water is produced with an 18%–17% probability and the production of oxygen atoms is negligible. These results support the three-body break-up dominance already found by Vejby-Christensen et al. for the DR of H3O+ in a similar heavy-ion storage ring experiment. However, even if the general trend is the same for both storage rings, significant differences have been observed and will be discussed.
A high-throughput pKa screening method based on pressure-assisted capillary electrophoresis (CE) and mass spectrometry (MS) is presented. Effects of buffer type and ionic strength on sensitivity and pKa values were investigated. Influence of dimethyl sulfoxide (DMSO) concentration present in the sample on effective mobility measurement was examined. A series of ten volatile buffers, covering a pH range from 2.5 to 10.5 with the same ionic strength, was employed. The application of volatile background electrolytes resulted in significant signal increase as compared with commonly used non-volatile phosphate buffers. In general, the CE/MS system provided a ten-fold higher sensitivity than conventional UV detection. The newly developed CE/MS method offers high-throughput capacity by pooling a number of compounds into a single sample. Simultaneous measurement of more than 50 compounds was readily achieved in less than 150 min. The measured pKa values are consistent with the published data obtained from the CE/UV method and are also in good agreement with data generated by other methods. Other advantages of using CE/MS for pKa screening are illustrated with typical examples, including poorly soluble compounds and non-UV-absorbing compounds.
Background and Objective Several review articles have been published discussing gastric acid-related drug-drug interactions (DDIs) mediated by coadministration of antacids, histamine H 2 receptor antagonists, or proton pump inhibitors, but are not sufficiently comprehensive in capturing all documented DDIs with acid-reducing agents (ARAs) and tend to focus on gastric pH-dependent DDIs and/or basic drugs. Subsequently, several new drugs have been approved, and new information is available in the literature. The objective of this systematic review is to comprehensively identify oral medications that have clinically meaningful DDIs, including loss of efficacy or adverse effects, with gastric ARAs, and categorize these medications according to mechanism of interaction. Methods An indepth search of clinical data in the PDR3D: Reed Tech Navigator™ for Drug Labels, University of Washington Drug-Drug Interaction Database, DailyMed, Drugs@FDA.gov, and UpToDate ® /Lexicomp ® Drug and Drug Interaction screening tool was conducted from 1 June to 1 August 2018. The PDR3D, University of Washington Drug-Drug Interaction Database, and DailyMed were searched with terms associated with gastric acid and ARAs. Conflicting findings were further investigated using the UpToDate ® /Lexicomp ® screening tool. Clinical relevance was assessed on whether an intervention was needed, and prescribing information and/or literature supporting the DDI. Results Through the search strategy, 121 medications were found to clinically meaningfully interact with ARAs. For 38 medications the mechanism of interaction with ARAs was identified as gastric pH dependent, and for 83 medications the interaction was found to be not gastric pH mediated, with mechanisms involving metabolic enzymes, transporters, chelation, and urine alkalization. Additionally, 109 medications were studied and did not have a clinically meaningful interaction with ARAs. Conclusion This review may provide a resource to healthcare professionals in aiding the care of patients by increasing awareness of interactions with ARAs and may also identify and potentially aid in avoiding clinically relevant DDIs and preventing risk of treatment failure and/or adverse effects. Advances in non-clinical predictions of gastric pH-mediated DDIs may guide the need for a future clinical evaluation. Key PointsThis review provides an evaluation of the effectiveness and safety of currently available medicines when taken with medicines used to control stomach acid.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.